MRI characteristics of proctitis in Crohn’s disease on perianal MRI by unknown
MRI characteristics of proctitis in Crohn’s
disease on perianal MRI
Charlotte J. Tutein Nolthenius,1,3 Shandra Bipat,1 Banafsche Mearadji,1
Anje M. Spijkerboer,1 Cyriel Y. Ponsioen,2 Alexander D. Montauban van Swijndregt,3
Jaap Stoker1
1Department of Radiology, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam,
The Netherlands
2Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, PO Box 22700,
1100 DE Amsterdam, The Netherlands
3Department of Radiology, OLVG, PO Box 99550, 1090 HM Amsterdam, The Netherlands
Abstract
Purpose: Multiple features have been described for
assessing inflammation in Crohn’s disease (CD) in MR
enterography, but have not been validated in perianal
magnetic resonance imaging (MRI). Retrospectively, we
studied which MRI features are valuable in assessing
proctitis.
Materials and methods: CD patients (‡18 years) who
underwent colonoscopy (reference standard) and peri-
anal fistula MRI within 8 weeks were included. Seven-
teen MRI features were blindly scored by three observers
and correlated to endoscopy (regression analysis).
Reproducibility (multirater kappa, intraclass correlation
coefficient) was determined for all three observer pairs.
MRI features were considered relevant when signifi-
cantly correlated to endoscopy for ‡2 observers, and
reproducibility was ‡0.40 for ‡2 observer pairs.
Results: Perianal MRI of 58 CD patients were included.
Wall thickness, rectal mural fat, creeping fat, and size of
mesorectal lymph nodes showed a significant correlation
with endoscopy for ‡2 observers (p = 0.000–0.023,
p = 0.011–0.172, p = 0.007–0.011 and p = 0.000–
0.005, respectively) with a kappa/intraclass correlation
coefficient of ‡0.60 for ‡2 observer pairs. Perimural T2
signal and perimural enhancement significantly corre-
lated to endoscopy (all p values £0.05) for all three
observers and the reproducibility was ‡0.40 for ‡2
observer pairs. Mural T2 signal and degree and pattern
of T1 enhancement showed significant correlation to
endoscopy for two observers, but with poor to moderate
reproducibility.
Conclusion: Wall thickness, mural fat, and mesorectal
features (perimural T2 signal, perimural enhancement,
creeping fat, and size of mesorectal lymph nodes) had
significant correlation to endoscopy and were repro-
ducible in diagnosing proctitis. Some established luminal
features in MRE were considered not useful.
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Magnetic resonance imaging (MRI) of the perianal region
has proven to be a valuable tool in diagnosing perianal
ﬁstulas in patients with Crohn’s disease, with accuracies
reported up to 93% in classifying ﬁstulas and 96% in
delineating abscesses [1, 2]. The anatomy and complexity
of the fistula tract can precisely be depicted which is
important for treatment planning [3]. Preoperative MRI
has shown to reveal additional and clinically relevant
information, thereby reducing recurrence rates after fis-
tula surgery [1, 4]. Another important issue in treatment
planning is the concomitant presence of proctitis. Proctitis
is defined as an inflammation of the rectum, approxi-
mately 12–15 cm from the dentate line. In the presence of
proctitis, the chance of fistula healing is reduced, and
therefore, a more aggressive medical therapy should be
started and surgery should be avoided [3, 5, 6].
Extensive research revealed multiple MRI features
and scoring systems able to accurately assess inﬂamma-
tion in luminal Crohn’s disease [7–9]. These features have
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been assessed on MR enterography or MR colonogra-
phy, and have not been tested in dedicated pelvic MRI,
which is limited by a different scan protocol (small FOV,
other sequences) and the absence of luminal contrast. As
many patients with perianal fistulas will undergo a pelvic
MRI before start of treatment, diagnosing the presence
and degree of proctitis on this MRI could be of addi-
tional value [2, 3].
In our retrospective study, we aimed to identify the
MRI features of proctitis on a dedicated pelvic MRI, and




From January 2001 until February 2014, we searched the
endoscopy database (EndoAlpha Documentation,
Olympus Nederland BV, Zoeterwoude, The Netherlands)
of the Academic Medical Center, Amsterdam, The
Netherlands, for patients (‡18 years of age) with known
Crohn’s disease who underwent a proctoscopy, sigmoi-
doscopy, or colonoscopy and who also underwent a ded-
icated pelvic MRI according to our standard MRI
perianal ﬁstula protocol within either 8 weeks prior to or
after endoscopy. We chose this eight-week interval bal-
ancing inclusion versus a satisfactory interval. Patients
were included if the endoscopy report mentioned the rec-
tum, either with regard to the diagnosis of proctitis, rectal
inﬂammation, or rectitis orwith regard to no signs of rectal
inﬂammation at all. Patients could only be included once.
In that case, the most recent MRI was chosen. For con-
sistency, MRIs performed with an endocoil or with an
incomplete scan protocol were excluded. Electronic med-
ical records were searched by a research fellow (CTN) and
relevant information was noted (time of diagnosis, use of
medication during the examinations, previous surgery).
Patients with change in therapy, eithermedical or surgical,
in the period between endoscopy andMRI were excluded.
All included MRI scans were blinded and randomly
ordered.
The requirement for review by the Medical Ethical
Committee or informed consent was waived because of
the retrospective nature of this study with pre-existing
data.
Reference standard
With no access to clinical information or MRI scans, we
evaluated the endoscopy reports of all included patients
and performed a classiﬁcation of lesion severity by con-
sidering three categories: grade (1) absence of lesions;
grade (2) presence of inﬂammatory lesions without
ulceration, including erythema, oedema, pseudopolyps,
and aphthae; and grade (3) presence of superﬁcial or
deep ulcerations [10]. The presence or absence of fistulas
and anal stenosis was also noted. Uncertainties were
resolved by the expert opinion of a gastroenterologist
(CY; 20 years of experience), with inflammatory bowel
disease as subspecialty, with access to all endoscopical
information, including endoscopy images.
MRI protocol
All MRIs were performed at 1.5T (Signa Horizon
Echospeed, LX 9.0, General Electric Medical Systems,
Milwaukee, WI, USA and MAGNETOM Avanto,
Siemens Healthcare, Erlangen, Germany) and at
3T (INTERA, Philips Medical Systems, Best, the
Netherlands) without bowel preparation, except 4-h
fasting. Patients were scanned in supine position using a
torso phased-array surface coil. Sagittal, coronal, and
transversal sequences were performed with the coronal
and transversal sequences angulated parallel and per-
pendicular to the anal canal, respectively. The scan
protocol consisted of T2-weighted Turbo Spin-Echo se-
quences in the sagittal, coronal, and transversal planes, a
fat-suppressed transversal T2-weighted TSE sequence
and a fat-suppressed transversal T1-weighted TSE se-
quence after intravenous gadolinium. For a detailed
description of all MRI parameters see Appendix A.
Observers
All MRI scans were blinded and retrospectively evalu-
ated by three abdominal radiologists with different rel-
evant experience levels: Observer 1 (BM; abdominal
radiologist for 9 years including approximately 500
perianal ﬁstula MRIs and 500 MR enterographies) years,
observer 2 (AS; radiologist for 20 years including
approximately 300 perianal ﬁstula MRIs and 300 MR
enterographies), and observer 3 (JS; abdominal radiolo-
gist for 21 years including approximately 1300 perianal
ﬁstula MRIs and 800 MR enterographies). No clinical or
endoscopy ﬁndings were provided, except for the pres-
ence or absence of perianal ﬁstulas. . Before start, the
observers read a document explaining the different MRI
features to be evaluated with examples obtained from the
previous literature and cases from a different dataset
followed by a joined session discussing the features led by
a fellow researcher (CTN) and the most experienced
abdominal radiologist (observer 3: JS) (Fig. 1) [7, 11–14].
Five example cases from a different dataset were dis-
cussed. For evaluation of all cases, a digital question-
naire was developed (proctitis.co.nr).
MRI features
Quality of the scan and rectal distention were evaluated
by the most experienced observer as poor (non-diag-
nostic), adequate (artifacts, but sufﬁcient diagnostic
quality), and good (no artifacts); and none (completely
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collapsed rectum), moderate (some distension but no
convex contours of the rectal wall), and good (convex
contours of the rectal wall) assessed in the least distended
part of the rectum, respectively. Seventeen MRI features
(Table 1) were evaluated by all three readers. Features
were selected according to MRI features described in the
literature and those used in two published scoring sys-
tems on MRI in luminal Crohn’s disease [7, 10, 11].
Definitions of certain features were adapted to be
applicable in perianal MRI (Table 1). Additional items
according to expert opinion were added: enhancement of
perimural fat tissue (see Table 1; Fig. 1 for definition),
creeping fat was defined as an increased amount of
perirectal fat tissue and the comb sign as increased vas-
cular structures in the perirectal fat, both scored on the
sagittal images. The most affected part of the rectum was
Fig. 1. Axial oblique fat-saturated post-contrast T1-weighted
images of four different patients with Crohn’s disease with
different degrees of perimural enhancement. A Equivalent to
normal fat tissue. B Minor enhancement. There is blurred
demarcation of the bowel wall with or without mild increase of
perimural fat tissue signal. C Moderate enhancement. In-
crease of perimural fat tissue signal but less than nearby
vascular structures. D Marked enhancement. Perimural fat
tissue signal approaches that of nearby vascular structures.
Mesorectal fascia enhancement can be noted.
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evaluated. Shortest axis of the largest lymph node per
station was measured.
Statistical analysis
The maximum number of eligible patients in the given
time period were included, and no sample size calcula-
tions were therefore performed. Extension of this time
period to earlier period was not desirable, as the MRI
protocol was different before 2001 (use of endocoil) and
thereby not reﬂecting the practice nowadays.
Normality of continuous data was tested by visual
assessment of the data. Normally distributed data were
presented with means and SD. For non-normally dis-
tributed data, medians with interquartile ranges (IQR)
were given.
Interobserver agreement
Several multirater analyses were performed for all fea-
tures individually. To test the level of interobserver
agreement for the separate MRI features between the
three different pairs of radiologists, the appropriate
measure was used. For all ordinal data, a weighted
kappa coefﬁcient was calculated per two raters. For the
binominal data, a kappa coefﬁcient was used calculated
per two raters. For continuous data, an intraclass cor-
relation coefﬁcient was determined per two raters. Both
kappa and intraclass correlation coefﬁcient values were
interpreted as follows: 0–0.20, poor; 0.20–0.40, fair; 0.40–
0.60, moderate; 0.60–0.80, good; 0.80–1.00, very good
[15].
Comparison of observers with reference standard
Endoscopical reference standard was dichotomized in the
absence of lesions (grade 0) versus proctitis (grades 1 and
2) because of limited size of study population. Associa-
tions were tested using regression analyses for ordinal or
binominal MRI parameters. Comparison of continuous
MRI parameters and endoscopical reference standard
was performed using the Mann–Whitney U test, as data
were not normally distributed.
Relevant MRI features
MRI features with a signiﬁcant correlation (p value of
£0.05) between the reference standard and at least two of
three observers, and with a (weighted) kappa/intraclass
correlation coefficient value of ‡0.60 for at least two of
three observer pairs, were identified and considered
potentially relevant in diagnosing proctitis. In post hoc
analysis, threshold for the kappa/intraclass correlation in
considering a relevant feature was changed to ‡0.40,
because this concerns an initial study aimed at identify-
ing potential relevant features and therefore sufficient
features should be identified to be used in a future vali-
dation study.
All statistical analyses were performed with IBM
SPSS Statistics version 20.0 for Windows (SPSS, Chica-
go, IL, USA) and Vassarstats.com (Richard Lowry,
Poughkeepsie, NY, USA).
Results
Patient and MRI characteristics
Between January 2001 and February 2014, 106 Crohn’s
disease patients were extracted from the database who
underwent perianal MRI within 8 weeks of endoscopy
(Fig. 2). After exclusion, a total of 58 patients remained
(Fig. 2), of which 21 (36%) are male with a mean age of
38.7 (SD 12.6) at the time of MRI. The median time
between MRI and endoscopy was 12 days ([IQR 6–21];
range 0–44). Thirty-two (55%) had no signs of proctitis
at endoscopy and 26 (45%) had signs of proctitis, of
which 19 (33%) had non-ulcerative proctitis and 7 (12%)
ulcerative proctitis. Table 2 summarized the demo-
graphic and clinical data of patients included in the
study.
Quality of the MRI scans was considered good in
74.1% (43/58) and adequate in 25.9% (15/58). There was
no rectal distention in 43.1% (25/58), moderate disten-
tion in 34.5% (20/58), and good distention in 22.4% (13/
58).
Interobserver agreement
Agreement between the three observer pairs is presented
in Table 3. For size of mesorectal lymph nodes, the
agreement for all three pairs ranged between good and
very good (0.78 and 0.83). Wall thickness, mural fat, and
creeping fat showed good agreement for two of three
observer pairs (0.70–0.58–0.69, 0.67–0.57–0.64, and
0.48–0.69–0.76, respectively). Perimural T2 signal,
supralevatoric extension of fistula, and abscess showed at
least moderate agreement (‡0.40) for all the three ob-
server pairs. Perimural enhancement and size of inguinal
lymph nodes showed at least moderate agreement for
two of three observer pairs (0.46–0.34–0.59 and 0.65–
0.38–0.43).
Comparison of observers with reference standard
In Table 4, the comparison of continuous variables
(upper part) and ordinal variables (lower part) with the
reference standard are presented. Wall thickness was
significantly smaller for all three observers in patients
without proctitis than in patients with proctitis (observer
1: 6.0 vs. 9.0 mm, p = 0.000; observer 2: 8.0 vs.
11.0 mm, p = 0.023; observer 3: 4.0 vs. 10.0 mm,
p = 0.000).
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Fig. 2. Flow chart of
search in hospitals’ patient
database.
Table 2. Demographic characteristics of the study population
Study group Control group
No. (%) of patients 26 (55) 32 (45)
Men (%) 13 (50) 8 (25)
Women (%) 13 (50) 24 (75)
Age at time of imaging (y), median (IQR) 40 (27–51) 37 (28–47)
Disease duration (y), median (IQR) 7 (4–11) 7 (3–21)
Days between endoscopy and MRI, median (IQR) 13 (7–23) 11 (4–20)
Previous surgery, no. (%) of patients 16 (62) 22 (69)
Maintenance therapy, no. (%) of patients 18 (69) 23 (72)
Antitumor necrosis factor, no. (%) of patients 5 (19) 11 (34)
Steroids, no. (%) of patients 8 (31) 3 (9)
Immunosuppressant, no. (%) of patients 12 (46) 12 (38)
5-Aminosalicylic acid medications, no. (%) of patients 1 (4) 7 (22)
Vedolizumab, no. (%) of patients 1 (4) 0
Presence of fistula (on MRI)
None, no. (%) of patients 3 (12) 8 (25)
Simple, no. (%) of patients 11 (42) 16 (50)
Complex, no. (%) of patients 12 (46) 8 (25)
Endoscopy diagnosis
Absence of lesions, no. (%) of patients 0 32 (100)
Non-ulcerative lesions, no. (%) of patients 7 (27) 0
Ulcerations, no. (%) of patients 19 (73) 0
IQR interquartile range
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Mesorectal lymph nodes were smaller for all three
observers in patients without proctitis than with proctitis
(observer 1: 3.0 vs. 5.0 mm, p = 0.001; observer 2: 4.0
vs. 6.0 mm, p = 0.005; observer 3: 3.0 vs. 6.0 mm,
p = 0.000).
Percentage of circumference involved, perimural T2
signal, perimural enhancement, and the presence of the
comb sign showed also a signiﬁcant correlation between
all three observers and the endoscopy reference standard
(Table 4).
Table 3. Multirater Kappa and intraclass correlation coefficient values between the observer pairs
MRI features 1 vs. 2 2 vs. 3 1 vs. 3
Wall thickness 0.70 (0.54–0.81) 0.58 (0.38–0.73) 0.69 (0.53–0.81)
Mesorectal lymph nodes 0.83 (0.72–0.89) 0.78 (0.66–0.87) 0.83 (0.72–0.89)
Obturator lymph nodes 0.31 (0.06–0.53) 0.26 (0.00–0.48) 0.27 (0.01–0.49)
Iliac lymph nodes 0.38 (0.14–0.58) 0.23 (-0.03–0.46) 0.24 (-0.01–0.47)
Inguinal lymph nodes 0.65 (0.48–0.78) 0.38 (0.14–0.58) 0.43 (0.20–0.62)
% of circumference involved 0.16 (0.03–0.29) 0.17 (0.06–0.27) 0.47 (0.27–0.67)
Mural T2 signal 26% (15/58)a 43% (25/58)a 41% (24/58)a
Perimural T2 signal 0.50 (0.34–0.67) 0.57 (0.41–0.73) 0.71 (0.58–0.85)
T1 enhancement 0.13 (0.03–0.24) 0.14 (0.01–0.27) 0.39 (0.22–0.56)
T1 enhancement pattern 0.13 (0.02–0.25) 0.25 (0.12–0.38) 0.43 (0.25–0.61)
Perimural enhancement 0.46 (0.29–0.64) 0.34 (0.17–0.50) 0.59 (0.42–0.76)
Mural fat 0.67 (0.44–0.90) 0.57 (0.34–0.81) 0.64 (0.37–0.90)
Ulcers 64% (37/58)a 0.13 (0–0.39) 0.25 (0–0.57)
Supralevatoric fistula 0.48 (0.24–0.72) 0.57 (0.31–0.82) 0.59 (0.39–0.79)
Supralevatoric abscess 0.53 (0.21–0.86) 0.53 (0.24–0.82) 1
Creeping fat 0.48 (0.18–0.77) 0.69 (0.46–0.92) 0.76 (0.53–0.98)
Comb sign 0.18 (0.01–0.34) 0.20 (0.03–0.36) 0.55 (0.32–0.78)
a Proportion of agreement calculated instead of kappa, because observed concordance is smaller than mean-chance concordance
Table 4. Comparison of observers with reference standard
MRI Features Observer 1 Observer 2 Observer 3
Median (IQR) p value Median (IQR) p value Median (IQR) p value
Wall thickness (mm) Normal 6.0 [4.0–8.0] 0.000 8.0 [7.0–12.0] 0.023 4.0 [3.0–6.8] 0.000
Proctitis 9.0 [7.0–10.5] 11.0 [9.8–12.0] 10.0 [7.0–12.3]
Mesorectal lymph nodes (mm) Normal 3.0 [2.0–4.8] 0.001 4.0 [0.0–5.8] 0.005 3.0 [0.5–5.0] 0.000
Proctitis 5.0 [4.0–7.0] 6.0 [4.8–7.3] 6.0 [4.0–8.0]
Obturator lymph nodes (mm) Normal 5.0 [4.0–7.0] 0.647 5.0 [0.0–6.0] 0.535 4.0 [3.0–5.0] 0.905
Proctitis 6.0 [2.3–7.0] 5.0 [2.3–6.0] 4.0 [3.0–5.3]
Iliac lymph nodes (mm) Normal 5.0 [0.0–7.0] 0.375 5.0 [4.0–7.0] 0.855 0.0 [0.0–4.0] 0.403
Proctitis 6.0 [4.0–7.0] 6.0 [0.0–7.0] 0.0 [0.0–4.3]
Inguinal lymph nodes (mm) Normal 8.0 [7.0–9.8] 0.442 8.0 [7.0–9.8] 0.427 8.0 [6.0–10.0] 0.575
Proctitis 7.0 [6.0–10.0] 7.0 [6.0–9.0] 7.0 [6.0–10.0]
MRI Features Observer 1 Observer 2 Observer 3
Exp(B) (95% CI) p value Exp(B) (95% CI) p value Exp(B) (95% CI) p value
% of circumference involved 14.18 (3.60–55.87) 0.000 12.65 (2.60–61.65) 0.002 9.90 (2.96–31.09) 0.000
Mural T2 signal 4.34 (1.58–11.91) 0.004 3.16 (1.07–9.37) 0.038 3.90 (1.07–16.30) 0.062
Perimural T2 signal 20.43 (4.13–100.99) 0.000 4.79 (1.72–13.34) 0.003 20.25 (4.95–85.76) 0.000
T1 enhancement 3.10 (1.15–8.18) 0.025 2.16 (1.30–6.10) 0.145 2.69 (1.01–7.17) 0.049
T1 enhancement pattern 2.48 (1.05–6.46) 0.064 6.28 (2.00–19.71) 0.002 2.89 (1.11–7.57) 0.030
Perimural enhancement 11.70 (3.27–41.85) 0.000 9.06 (2.81–29.22) 0.000 17.76 (4.35–74.07) 0.000
Mural fat 6.67 (1.28–34.92) 0.025 2.23 (0.71–7.06) 0.172 16.41 (1.91–140.75) 0.011
Ulcers 0.47 (0.11–2.02) 0.307 1.11 (0.34–3.60) 0.868 9.30 (1.04–83.13) 0.046
Supralevatoric fistula 1.25 (0.44–3.56) 0.673 1.60 (0.46–5.52) 0.460 1.93 (0.57–6.51) 0.291
Supralevatoric abscess 5.64 (0.59–53.93) 0.133 3.11 (0.82–11.86) 0.096 5.64 (0.60–53.93) 0.133
Creeping fat a 7.09 (1.71–29.35) 0.007 16.41 (1.91–140.75) 0.011
Comb sign 7.00 (1.91–25.67) 0.003 5.96 (1.48–23.97) 0.012 13.18 (3.18–54.57) 0.000
a Not calculated because of the presence of a zero in the crosstab
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Mural T2 signal, T1 enhancement, T1 enhancement
pattern, and creeping fat showed a signiﬁcant correlation
for two of three observers. Ulcers and supralevatoric
extension of ﬁstula and abscess did not show a signiﬁcant
correlation to the reference standard for all three ob-
servers.
Relevant MRI features
Based on predeﬁned criteria, the following MRI features
were considered most relevant in diagnosing proctitis
(Tables 3, 4): wall thickness, size of mesorectal lymph
nodes, mural fat, and creeping fat showed a significant
Fig. 3. Sagittal T2-weighted image of two different patients
with Crohn’s disease. A A 25-year-old female with ulcerative
proctitis at endoscopy. The image shows increased amount of
mesorectal fat tissue (creeping fat) and a subtle increase of
perimural vascularity (‘comb sign’) in addition to rectal wall
thickening. B A 24-year-old female with no signs of proctitis at
endoscopy. There is no increased amount of mesorectal fat
tissue and the rectum shows no abnormal MRI features.
Fig. 4. A 53-year-old female with Crohn’s disease and
ulcerative proctitis at endoscopy. A Axial oblique T2-weighted
image shows high mural signal intensity and B low signal
intensity on axial oblique fat-saturated T2-weighted image
corresponding tomural fat (arrow).CAxial oblique fat-saturated
post-contrast T1-weighted images shows moderate enhance-
ment of the rectal wall and perimural fat tissue. In addition, wall
thickening and multiple mesorectal lymph nodes are present.
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correlation between at least two of three observers and
the endoscopy reference standard, as well as a kappa/
intraclass correlation coefficient of ‡0.60 for at least two
of three observer pairs (Figs. 3, 4). In post hoc analysis, a
kappa/intraclass coefficient threshold of ‡0.40 was con-
sidered, which included perimural T2 signal and per-
imural enhancement as they showed a moderate
interobserver agreement for two of three observer pairs
and a significant correlation with the reference standard
for all three observers (Appendix B) (Fig. 5).
All other features (all other lymph nodes, % of cir-
cumference involved, T1 enhancement (pattern), ulcers,
supralevatoric ﬁstula, and abscess and comb sign) did
not fulﬁll our predeﬁned criteria for relevancy. Although
the correlation with endoscopy was signiﬁcant for two
observers, mural T2 signal and T1 enhancement (pattern)
showed poor to moderate agreement.
Discussion
MRI features rectal wall thickness, mesorectal lymph
nodes, mural fat, and creeping fat were considered rele-
vant in diagnosing proctitis on pelvic MRI, as they
showed a signiﬁcant correlation between at least two
observers and the endoscopy reference standard, and at
least a good interobserver agreement for at least two of
Fig. 5. A 49-year-old female with Crohn’s disease. A Axial
oblique T2-weighted image and B axial oblique fat-saturated
T2-weighted image show rectal wall thickening, a marked
increase of T2 signal intensity and a perimural large fluid rim
(>2 mm). C Axial oblique fat-saturated post-contrast T1-
weighted images obtained at the same level shows a mod-
erate enhancement of the rectal wall and the perimural fat
tissue. In addition, there is creeping fat and a supralevatoric
abscess left anterolateral of the rectum on all three images. D
Endoscopy showed ulcerative proctitis.
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three observer pairs. Perimural T2 signal and perimural
enhancement showed a signiﬁcant correlation for all the
three observers and a moderate interobserver agreement
for at least two of the three observer pairs. Mural T2
signal and T1 enhancement degree and pattern showed
poor to moderate reproducibility.
This is to our knowledge, the ﬁrst study reporting on
the speciﬁc MRI features associated with proctitis on a
dedicated pelvic MRI. Previous research did study rectal
involvement in Crohn’s disease patients, but this was done
using MR enterography or MR colonography [8–10]. No
specific rectal and/or perirectal features were described.
Van Assche developed an MRI-based score of perianal
Crohn’s disease severity with rectal wall thickening as the
sole indicator for rectal inflammation, which can be used
for evaluationof response to treatment [16, 17].Our results
confirmed the correlation between rectal wall thickening
and inflammation; in addition, a moderate to good inter-
observer agreement was observed. Most features consid-
ered relevant in diagnosing proctitis involved the
mesorectal fat tissue (Figs. 4, 5). This is in contrast to a
study that showed only fair reproducibility for perimural
features on MR enterography [11]. Crohn’s disease is
known for its transmural inflammation and subsequent
perimural involvement. In the rectum, this perimural
involvement was often quite prominent. This might be
related to the isolated localization of the rectum sur-
rounded bymesorectal fat tissue, where perimural changes
are somewhat easier appreciated thanwhenmultiple loops
of bowel are closely aligned. Further, the rectum was not
or moderately distended in most cases, which might result
in the perirectal features becoming more apparent. This
rectal collapse might have led to increased wall thickness
measurements. Even so, there was a significant difference
inwall thickness in proctitis versus no proctitis as observed
by all three observers. Further research should focus on
the predictive value of the individual MRI features iden-
tified in our study, and the clinical use in monitoring
treatment response as a non-invasive alternative to endo-
scopy and in case of severe anal stenosis.
In contrast, luminal features already proven to be
useful in establishing disease severity onMRenterography
Fig. 6. A 45-year-old male with Crohn’s disease and no
signs of proctitis at endoscopy. A Axial oblique T2-weighted
image and B axial oblique fat-saturated T2-weighted image
obtained at the same level shows a moderate increase of T2
signal intensity of the rectal wall.
Fig. 7. A 43-year-old male with Crohn’s disease and ulcer-
ative proctitis at endoscopy. Sagittal T2-weighted image
shows the increased perimural vascularity perpendicular to
the rectum (‘comb sign’) in addition to the wall thickening of
the entire rectum.
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and MR colonography, for example, T2 signal intensity
and T1 enhancement (pattern and degree), were consid-
ered not useful in our study [7–9]. In order to decide if a
certain feature is considered normal or increased, onemust
be able to compare it to other colonic loops, which were
almost never included in the field of view of the T1-
weighted and T2-weighted fat-saturated sequences that
was only performed in the axial oblique plane. Also, in our
standard perianal fistula protocol, no T1-weighted pre-
contrast images for comparison were performed. For the
T2 signal intensity of the rectal wall in almost all cases
(normal or proctitis), observers scored the T2 signal
intensity of the rectal wall at least as slight, but mostly as
moderately increased (Fig. 6). This suggests that the nor-
mal rectal signal intensity is already light gray on T2 fat-
saturated images and that the grading scale used for
luminal disease was not adequate for the rectum. Fur-
thermore, MR enterography and colonography use
luminal contrast to obtain bowel distention.
We do not have a balanced explanation for the lack of
correlation between the supralevatoric extension of ﬁs-
tula and/or abscess and the presence of proctitis as one
might have expected. Only our most experienced ob-
server showed a signiﬁcant correlation for the presence of
ulcerations. A limitation for this feature is that in the
proctitis group, we combined the patients with non-
ulcerative and ulcerative proctitis because of low number
of patients in each group. As the number of ulcerative
proctitis cases was low, a possible correlation in ulcera-
tive proctitis might not be identiﬁed. Combining ulcera-
tive and non-ulcerative proctitis, also prevented us to
rule on disease severity. For the features ‘presence of
creeping fat’ and ‘comb sign,’ we had no circumscribed
deﬁnitions or grading, and observers had to score these
features according to their expert opinion rendering it
susceptible for subjectivity. Although the comb sign did
show a signiﬁcant correlation with endoscopy, the
interobserver agreement was very low for two of three
observer pairs, probably because of unfamiliarity with
this feature (Fig. 7).
Increased wall thickness is not only seen in the active
phase ofCrohn’s disease but also in the chronic stage of the
disease.Also, the presence ofmural fat and creeping fat are
signs of chronic disease. The signiﬁcant correlation to ac-
tive inﬂammation at endoscopy for these features is
inherent to Crohn’s disease with a chronic course of
relapsing and remitting inﬂammation, where features of
chronic disease coexist with acute inﬂammatory changes.
Our study has several limitations. First, endoscopy
reports were retrospectively analyzed in order to deter-
mine the reference standard. However, only reports with
evident mentioning of the rectum were included and
evaluated using a predeﬁned clear-cut scoring system [10]
and an experienced gastroenterologist was involved.
Because of only including patients with mentioning of
the rectum in the endoscopy report, our patient popu-
lation was subject to selection bias creating a disease-
enriched population. Second, the time between the MRI
and the endoscopy examination ranged from 0 to
44 days. In this time frame disease activity could have
been altered because of natural course. However, since
we excluded all patients with change in medical or sur-
gical therapy during the time interval, this possibility was
minimized. Third, the use of a kappa/intraclass coeffi-
cient value of ‡0.60 would have strengthened our study,
but at initial evaluation of our data too little features
remained. In this first phase of identifying possible rele-
vant features, we wanted to include as much features as
possible, in order to make a further selection in a future
validation study. Fourth, the introductory session for the
observers regarding the different MRI features was held
by the same expert abdominal radiologist (JS who was
also one of the readers in this study), which could have
increased reproducibility. We did not notice higher
agreement between the observer pairs including this ex-
pert abdominal radiologist than the other observer pair.
In conclusion, for diagnosing proctitis in Crohn’s
disease in perianal MRI, MRI features involving the
mesorectal tissue, perimural T2 signal, perimural T1
enhancement, the presence of creeping fat, and size of
mesorectal lymph nodes were most valuable, as they
showed a signiﬁcant correlation with endoscopical ﬁnd-
ings and were reproducible. Established luminal features
like mural T2 signal and T1 enhancement may be less
helpful in perianal MRI. In addition, rectal wall thick-
ness and presence of mural fat were relevant as well.
Future research should focus on these MRI features by
validating them in a prospective study and for deﬁning
thresholds for continuous variables.
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TSE with fat sat.
Axial T1-weighted
TSE with fat sat. +
iv contrast
enhancementa
1.5 T (Siemens, Avanto), 33 MR scans
Field of view (cm) 300 300/320 220/300 220/300 300–450
No. of slices 28–40 25–42 28–45 28–42 28–42
Repetition time (ms) 2500–4000 2500–4000 2500–4000 2500–4000 600–718
Echo time (ms) 69/70 70–121 70–121 70–121 9,4/11
Image matrix 512 9 231-512 9 578 256 9 297-512 9 575 256 9 297-512 9 578 256 9 297-512 9 575 256 9 288-512 9 256
Slice thickness (mm) 3/4 3/4 3/4 4 4
Slice gap (mm) 0.4 0–0,4 0–0.4 0/0.4 0–0,4
NSA 1–3 1/2 1/2 1/2 1–4
Flip angle 90/150 90/150 90/150 90/150 90/150
1.5 T (Signa, GE), 20 MR scans
Field of view (cm) 300 300 300 300 300/450
No. of slices 32 32 31/32 28–32 31/32
Repetition time (ms) 2500 2500 2500 2500–4500 560/600
Echo time (ms) 69/70 71/72 69 69–83 10.8
Image matrix 512 9 200 512 9 200 512 9 200 256 9 100 256 9 100
Slice thickness (mm) 4 4 4 4 4
Slice gap (mm) 0.4 0.4 0.4 0.4 0.4
NSA 1 1 1 1 2
Flip angle 90 90 90 90 90
3 T (Philips), 5 MR scans
Field of view (cm) 230–360 240–400 240–400 240–400 300/400
No. of slices 30–41 30–37 32–45 35–45 40–45
Repetition time (ms) 2689/3000 2689–3000 2689–3000 3000/4626 550–786
Echo time (ms) 70–100 70–100 70–100 70/100 10
Image matrix 256 9 198-528 9 361 400 9 246-528 9 400 400 9 395-528 9 361 300 9 287-768 9 287 248 9 248-512 9 255
Slice thickness (mm) 3/4 3/4 3/4 3/4 3/4
Slice gap (mm) 0–1 0/0.3 0/0.3 0/0.3 0/0.3
NSA 2/4 1/4 1/4 1/2 1/2
Flip angle 90 90 30 90 90
a With the exception of one SENSE dixon post-contrast series: FOV 400, no. of slices 480, TR 0, TE 0, matrix 512x207, slice thickness 1.5, gap 0,
averages 1, flip angle 8
Appendix B. Combined results of interobserver agreement and correlation between observers and reference standard
MRI features Significant correlation between observer and
reference standard (p £ 0.05)
Kappa or intraclass coefficient
‡0.40
Relevant MRI feature
Observer 1 Observer 2 Observer 3 1 vs. 2 2 vs. 3 1 vs. 3
Wall thickness Yes Yes Yes Yes Yes Yes Yes
Mesorectal lymph nodes Yes Yes Yes Yes Yes Yes Yes
Obturator lymph nodes No No No No No No No
Iliac lymph nodes No No No No No No No
Inguinal lymph nodes No No No Yes No Yes No
% of circumference involved Yes Yes Yes No No Yes No
Mural T2 signal Yes Yes No No Noa Noa No
Perimural T2 signal Yes Yes Yes Yes Yes Yes Yes
T1 enhancement Yes No Yes No No No No
T1 enhancement pattern No Yes Yes No No Yes No
Perimural enhancement Yes Yes Yes Yes No Yes Yes
Mural fat Yes No Yes Yes Yes Yes Yes
Ulcers No No Yes Noa No No No
Supralevatoric fistula No No No Yes Yes Yes No
Supralevatoric abscess No No No Yes Yes Yes No
Creeping fat b Yes Yes Yes Yes Yes Yes
Comb sign Yes Yes Yes No No Yes No
a Proportion of agreement calculated, because observed concordance is smaller than mean-chance concordance. Assuming kappa £0.40
b Not calculated because of the presence of a zero in the crosstab
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